Alterations of the Architecture of Subendocardial Arterioles in Patients With Hypertrophic Cardiomyopathy and Impaired Coronary Vasodilator Reserve: A Possible Cause for Myocardial Ischemia 11This study was supported by Grant SFB 242: Koronare Herzkrankheit: Prävention und Therapie akuter Komplikationen from the Deutsche Forschungsgemeinschaft, Bonn, Germany.  by Schwartzkopff, Bodo et al.
Alterations of the Architecture of Subendocardial Arterioles in
Patients With Hypertrophic Cardiomyopathy and Impaired Coronary
Vasodilator Reserve: A Possible Cause for Myocardial Ischemia
BODO SCHWARTZKOPFF, MD, MARKUS MUNDHENKE, MD,
BODO E. STRAUER, MD, FESC, FACC
Du¨sseldorf, Germany
Objectives. The study was designed to investigate the architec-
ture of subendocardial arterioles of patients with hypertrophic
cardiomyopathy (HCM) and angina pectoris with respect to
coronary vasodilator reserve.
Background. There is growing evidence that the coronary
microvasculature is abnormal in HCM. Arterioles, which mainly
regulate intramyocardial blood flow, are especially suspect.
Methods. Thirteen patients with HCM (50.1 6 12.6 years old,
mean value 6 SD) were studied after exclusion of any relevant
coronary stenoses. Subendocardial arterioles (density [n/mm2],
wall area [mm2], percent lumen area [%lumen], periarteriolar
collagen area [mm2]), myocyte diameter (mm) and interstitial
collagen fraction (Vv%) were evaluated by means of stereologic
morphometry of transvenous biopsy samples. Coronary blood flow
was measured quantitatively with the inert chromatographic
argon method at basal conditions and after dipyridamole
(0.5 mg/kg body weight over 4 min intravenously), and coronary
vasodilator reserve was calculated as the ratio of coronary resis-
tance at basal conditions and after pharmacologic vasodilation.
Data from five normotensive subjects (45.4 6 11 years old, p 5
NS) served as control data.
Results. Arteriolar density was diminished by 38% (p 5 0.004)
and %lumen by 13% (p 5 0.009) in patients with HCM compared
with control subjects. Coronary reserve was impaired in patients
with HCM (2.28 6 0.6 vs. 5.34 6 1.49, p 5 0.003) because of
higher coronary resistance after vasodilation (0.48 6 0.14 vs.
0.22 6 0.06 mm Hg 3 min 3 100 g/ml, p 5 0.004). Coronary
vasodilator reserve correlated with arteriolar density (r 5 10.47,
p 5 0.045) and with %lumen (r 5 0.65, p 5 0.003).
Conclusions. In HCM, the architecture of preterminal suben-
docardial arterioles is altered by a reduced total cross-sectional
lumen area, corresponding to an impaired coronary vasodilator
capacity that may predispose to myocardial ischemia.
(J Am Coll Cardiol 1998;31:1089–96)
©1998 by the American College of Cardiology
Hypertrophic cardiomyopathy (HCM) is a genetically trans-
mitted disease of the sarcomeres, characterized phenotypically
by an inappropriate thickness of the interventricular septum
and less frequently of the free left ventricular wall of a
nondilated ventricle (1,2). Apart from the striking pathologic
and molecular findings of the myocardium, recent reports
indicate that the coronary microcirculation is disturbed in
HCM. Atypical and typical chest pain are common symptoms
in patients with HCM. This is also the case in the context of
angiographically normal epicardial coronary arteries (3,4).
Thallium-201 imaging revealed reversible perfusion defects
both within the ventricular wall and especially in the subendo-
cardium (5). These were found to be associated with increased
myocardial lactate production, metabolic evidence of ischemia
(6). Previous reports indicate the important role of myocardial
ischemia in the development of symptoms and in relation to
prognosis (7,8). Several potential mechanisms for myocardial
ischemia have been proposed, including septal perforator
artery compression (9), abnormalities in diastolic relaxation
and filling that may impede myocardial oxygen delivery by
increased extravascular compressive forces (1,4), increased
oxygen demand due to dynamic outflow tract gradients (10),
myocardial bridges, abnormal intramyocardial small coronary
arteries (11) and an inadequate capillary density in relation to
the increased myocardial mass (12).
Furthermore, there is growing evidence that abnormalities
of intramural coronary arterioles may be the cause of myocar-
dial ischemia (13), especially as arterioles mainly regulate
intramural coronary blood flow (14,15) and their cross-
sectional area represents the intramural coronary resistance
(16).
The present investigation was designed to study the struc-
tural alterations of preterminal intramural arterioles in the
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right septal subendocardium by morphometric methods in
patients with hypertrophic cardiomyopathy and angina pectoris.
Methods
Patient selection. We studied 13 consecutive patients with
a clinical and echocardiographic diagnosis of HCM (septum
.15 mm, septum/posterior wall ratio .1.3 in the absence of
other known causes of left ventricular hypertrophy) (1) (Table
1). All patients reported typical or atypical chest pain and
exertional dyspnea (New York Heart Association functional
class II to IV, mean value 2.47 6 0.85), four patients com-
plained of presyncopy. All patients had been previously treated
with beta-blocking agents (n 5 4) or a calcium channel
blocking drug (verapamil, n 5 9) without significant ameliora-
tion of symptoms. All patients underwent cardiac catheteriza-
tion to assess the presence and severity of left ventricular
outflow tract obstruction and suitability for operation (septal
myectomy). Angiography excluded coronary artery stenoses of
.20% in each of the patients.
Five normotensive patients (mean age 45 6 11 years, p 5
NS) without echocardiographic evidence of HCM or dilative
cardiomyopathy and without valvular heart disease, and nor-
mal epicardial coronary arteries were investigated to exclude
unexplained chest pain (Table 1).
Echocardiographic studies. A transthoracic M-mode echo-
cardiogram, guided by a two-dimensional technique, was ob-
tained using a Toshiba SSH 140. M-mode echocardiography
was performed with a 2.25- or 3.5-MHz transducer. Basal
septal and posterior wall thicknesses were determined from the
M-mode echocardiogram according to the American Society of
Echocardiography (17), and the septum/posterior wall ratio
was calculated.
Measurement of central hemodynamic variables. Before
measuring the coronary circulation, the pressures in the pul-
monary artery, pulmonary capillary wedge position, right
atrium and aorta were measured with fluid-filled catheters.
Cardiac output was determined by thermodilution as the mean
value of at least three measurements. Quantitative biplane
ventriculography was performed (30° right anterior oblique,
60° left anterior oblique) by injecting 40 ml of nonionic
contrast medium (Ultravist-370, Schering Inc., Berlin, Ger-
many) into the left ventricle through a pigtail catheter at a
speed of 12 ml/s. Left ventricular end-diastolic volume (EDV)
and end-systolic volume (ESV) were determined semiautomat-
ically by the AVD system (Siemens Inc., Munich, Germany).
The left ventricular ejection fraction was calculated as (EDV 2
ESV)/EDV 3 100, and was .60% in each of the patients and
the controls. These investigations as well as the coronary
angiography were carried out between 3 and 5 days before the
measurement of the coronary circulation.
Evaluation of coronary vasodilator capacity. All medica-
tion was discontinued at the time of admission to the clinic.
Coronary blood flow was quantitatively measured using the
inert chromatographic argon method under baseline condi-
tions and after pharmacologic vasodilation, which occurs as
follows: gas chromatographic determination of the argon con-
centration of blood samples taken simultaneously from the
coronary sinus and the descending aorta while the patient is
breathing an oxygen-argon mixture (21% oxygen, 79% argon).
The aortic pressure was measured with a fluid-filled multipur-
pose catheter in the descending aorta. Coronary vascular
resistance was calculated as the coronary perfusion pressure
(coronary perfusion pressure equals mean systemic arterial
pressure minus mean right atrial pressure) divided by coronary
blood flow. Coronary reserve was calculated as the ratio of
coronary vascular resistance under basal conditions to coro-
nary resistance after coronary vasodilation by dipyridamole. To
avoid metabolic effects leading to an increase in left ventricular
obstruction, dipyridamole was given in a low dose (0.5 mg/kg
body weight) over a period of 4 min. Myocardial oxygen
consumption per unit weight of myocardium was determined
as the product of coronary blood flow per unit weight of
myocardium and the arterial-venous (coronary sinus) oxygen
difference. By this method, information about those regions
that drain into the coronary sinus can be derived. Advantages
Abbreviations and Acronyms
EDV 5 end-diastolic volume
ESV 5 end-systolic volume
EvG 5 elastic van Gieson
HCM 5 hypertrophic cardiomyopathy
HE 5 hematoxylin-eosin
%lumen 5 percent lumen area
Table 1. Clinical, Hemodynamic and Echocardiographic Data of
Patients With Hypertrophic Cardiomyopathy and Control Subjects
HCM
Group
Control
Group
p
Value
Clinical data
Gender (M/F) 10/3 3/2
Age (yr) 50.1 6 12.6 45.4 6 11.0 NS
Hemodynamic data
Systolic BP (mm Hg) 127.2 6 13.5 124.0 6 17.1 NS
Diastolic BP (mm Hg) 68.6 6 5.9 73 6 10.3 NS
Heart rate (beats/min) 71.4 6 9.9 74.4 6 10.7 NS
LV obstruction (gradient
.30 mm Hg at basal
conditions)
4/13 0
LVEF (%) 66 6 5 62 6 3 NS
Cardiac index
(liter/min per m2)
2.98 6 0.76 3.1 6 0.45 NS
LVEDP (mm Hg) 19.2 6 9.6 10.0 6 4.5 0.053
Echocardiography
Septum (mm) 24.7 6 6.0 10.8 6 1.3 0.001
Septum/posterolateral
wall ratio
2.24 6 0.68 0.98 6 0.02 0.001
LVEDD (mm) 41.8 6 4.9 48.0 6 4.1 0.02
Data presented are mean value 6 SD or number of subjects. HCM 5
hypertrophic cardiomyopathy; LV 5 left ventricular; LVEDD 5 left ventricular
end-diastolic diameter; LVEDP 5 left ventricular end-diastolic pressure;
LVEF 5 left ventricular ejection fraction.
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and disadvantages of the method have been discussed previ-
ously (18).
Morphologic investigation. Transvenous endomyocardial
biopsy was performed under biplane fluoroscopic control to
gain at least 6 samples from the right basal septum of each
patient. In the normal heart at least one arteriole was found in
a subendocardial biopsy sample of .1.22 mm2 (19). For an
appropriate estimate we evaluated five biopsy samples, each
having .1.22 mm2 of tissue section area, for each patient (19).
Samples were immediately fixed in 4% buffered formalin,
embedded in paraffin and numbered. Assuming the myocardial
structure to be partially anisotropic, special care has to be
taken to generate isotropic conditions for the sectioning of
biopsy samples that allow the application of common rules of
stereology (19,20). Therefore, each biopsy sample was embed-
ded into a sphere and rolled in random directions; thus
generating an isotropic uniform random section, which allows
measurement of the myocardial structure without bias (19,20).
Serial sections (n 5 5) of each biopsy sample were cut with a
thickness of 4 to 5 mm, and stained in hematoxylin-eosin (HE),
elastica van Gieson (EvG) and picro-Sirius red. Each section
area was planimetrically measured by a semiautomated image
analysis system (Quantimet 570, Cambridge, Leica). Differen-
tiation between arterioles and veins was done according to
Weiss and Conway (21,22) in the EvG-stained section, where
arterioles are characterized by a continuously stained yellow,
tunica media, a black lamina elastica, and a yellow-red tunica
adventitia. All profiles of intramyocardial arterioles were
counted independently from their form or direction. The mean
number of arterioles per square millimeter in the right septal
subendocardium for patients with HCM and for control sub-
jects was calculated from the mean number of each patient and
each control subject, determined from the arteriolar density
per square millimeter in sections .1.22 mm2. Morphometric
analysis of the single arteriolar wall was performed on strictly
transversely cut arteriolar profiles, resulting in a circular
appearance of the vessel, as previously reported (22) (Fig. 1).
Collagen was determined using picro-Sirius red, which specif-
ically stains collagen reddish and has been found to correlate
with the biochemical measurements of collagen content (23).
The following variables were determined for each patient: 1)
Mean myocyte diameter across the nucleus (mm): the mean of 20
measurements in each biopsy in HE stain at 4003 magnifica-
tion giving a mean of 100 measurements/patient. 2) Mean
volume density (Vv%) of interstitial collagen: the mean of
repeated measurements with 10 randomly distributed mea-
surements in one biopsy, at 1003 magnification using the color
image analysis system (Quantimet 570, Cambridge), giving a
mean total of 50 measurements/patient. 3) Numerical density of
arterioles (n/mm2) in EvG stain at 4003 magnification. 4)
Quantification of the wall of circular arteriolar profiles in EvG at
a 8003 magnification from all circular arteriolar profiles: a)
Wall area (mm2) and percent lumen area (%lumen): the lamina
elastica interna, including the intima, and the outer border of
the tunica media, marked by the tunica adventitia, were
surrounded by the computerized system, giving the absolute
area of the wall and the lumen area. The %lumen was derived
from lumen area/(lumen area 1 wall area) 3 100 (according to
ref. 13). b) Outer arteriolar diameter: from the total vascular
area the outer diameter of each arteriole was calculated,
excluding the adventitia (according to ref. 22). c) Periarteriolar
collagen (adventitia) area: as the periarteriolar collagen area
cannot be distinguished from the adventitial collagen, total
reddish stained collagen, surrounding each circular arteriole,
was measured by the computerized color detection system,
avoiding larger spaces.
The study protocol was approved by the ethics committee of
Heinrich-Heine University of Du¨sseldorf. Informed consent
was obtained from all patients before each investigation.
Figure 1. Intramural arterioles in transvenous sep-
tal endomyocardial biopsy specimen. All profiles
(A1B) were counted after measuring total biopsy
specimen area from isotropic sections (19,20). Wall
and lumen areas were determined from strictly
round arterioles (A) (EvG stain).
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Statistical analysis. Descriptive data are expressed as
mean value 6 SD. For interobserver and intraobserver vari-
ability the coefficient of variance and the coefficient of error
(calculated as coefficient of variance/=n) were given. The Wil-
coxon test, Mann-Whitney U test and linear regression analysis,
according to Pearson, were used where appropriate. Statistical
significance was inferred at a two-tailed p value of #0.05. The
analysis was done on the SPSS-PC package (Version 4.0).
Results
Clinical data. Major clinical data are given in Table 1. The
mean age of patients and control subjects did not differ. In four
patients, left ventricular outflow tract obstruction was
.30 mm Hg. Echocardiographically all patients had an irregular
hypertrophied septum and the left ventricular end-diastolic
diameter was small. Cardiac index, heart rate and systolic and
diastolic blood pressure were not significantly different in both
groups. Left ventricular end-diastolic pressure was higher in
the HCM group, but did not reach significance (p 5 0.053).
Coronary hemodynamic variables. There was no signifi-
cant difference between coronary blood flow and coronary
resistance at basal conditions between patients with HCM
and control subjects (Table 2). Furthermore, myocardial
oxygen consumption showed no difference at rest for both
groups. In the four patients with left ventricular obstruction
(.30 mm Hg) at basal conditions, coronary blood flow
(99.5 6 17.7 ml/min per 100 g), coronary resistance (0.898 6
0.136 mm Hg 3 min 3 100 g/ml) and myocardial oxygen
consumption (10.56 6 0.64 ml 3 min/100 g) did not differ
significantly from control values. After dipyridamole admin-
istration, in control subjects coronary blood flow was signif-
icantly higher and coronary resistance was significantly
lower than in patients with HCM. Thus, coronary reserve
was significantly impaired in patients with HCM.
Morphologic findings. In the right septal subendocardium
in HCM, myocytes showed a significant hypertrophy, collagen
content was increased and arteriolar density was significantly
reduced (Table 3). The mean diameter of arterioles was not
Figure 2. With increasing hypertrophy of myocytes (determined by
measuring their diameter), arteriolar density is reduced. Circles 5
control subjects (n 5 5); squares 5 patients with HCM (n 5 13).
Table 2. Coronary Hemodynamic Variables at Basal Conditions and
After Vasodilation in Patients With Hypertrophic Cardiomyopathy
and Control Subjects*
HCM
Group
(n 5 13)
Control
Group
(n 5 5)
p
Value
Basal conditions
Heart rate (beats/min) 71.4 6 9.9 74.7 6 10.7 NS
Mean aortic pressure (mm Hg) 86.7 6 12.3 90.6 6 8.0 NS
Coronary blood flow (ml/min
per 100 g)
91.6 6 20.0 81.2 6 16.8 NS
Coronary resistance
(mm Hg 3 min 3 100 g/ml)
1.03 6 0.24 1.11 6 0.24 NS
Myocardial oxygen consumption
(ml/min per 100 g)
10.8 6 1.98 10.4 6 2.6 NS
After vasodilation (dipyridamole
0.5 mg/kg body weight)
Heart rate (beats/min) 86.5 6 14.9 89.6 6 6.1 NS
Mean aortic pressure (mm Hg) 83.5 6 13.5 85.6 6 6.3 NS
Coronary blood flow
(ml/min per 100 g)
192.0 6 60.7 392.4 6 140.9 0.007
Coronary resistance
(mm Hg 3 min 3 100 g/ml)
0.477 6 0.143 0.218 6 0.063 0.004
Myocardial oxygen consumption
(ml/min per 100 g)
14.2 6 3.8 16.1 6 5.6 NS
Coronary reserve 2.28 6 0.60 5.34 6 1.49 0.003
*Coronary vasodilator reserve is impaired because of inadequate reduction
of coronary resistance after pharmacologic intervention. Data presented are
mean value 6 SD. HCM 5 hypertrophic cardiomyopathy.
Table 3. Morphometric Findings in the Right
Septal Subendocardium
HCM
Group
(n 5 13)
Control
Group
(n 5 5)
p
Value
Arteriolar density (n/mm2) 1.02 6 0.37 1.65 6 0.23 0.004
Arteriolar diameter (mm) 18.4 6 4.2 18.1 6 1.8 NS
Arteriolar wall area (mm2) 212.6 6 119.0 180.2 6 47.2 NS
%lumen area 23.89 6 2.003 27.51 6 2.23 0.009
Periarteriolar collagen area (mm2) 125.7 6 82.3 124.6 6 69.5 NS
Myocyte diameter (mm) 16.3 6 1.54 13.0 6 0.88 0.002
Collagen volume density (Vv%) 4.2 6 1.56 1.93 6 0.62 0.007
Arterioles have a lower density and a reduced percent lumen area (%lumen).
Myocyte hypertrophy and interstitial fibrosis, in terms of increased collagen
volume density (Vv%), are present. Data presented are mean value 6 SD.
HCM 5 hypertrophic cardiomyopathy.
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significantly different in HCM patients and controls, neverthe-
less their range for the group of patients with HCM (13.8 to
26.7 mm) was larger than in control subjects (15.12 to
19.53 mm). Quantitative data of %lumen revealed a significant
reduction in HCM (Table 3 and Fig. 3); the mean arteriolar
wall area and mean periarteriolar collagen area did not differ
significantly between patients with HCM and control subjects.
Univariate analysis revealed a significant negative correla-
tion between density of arterioles and myocyte size (Fig. 2).
Furthermore, the density of arterioles as well as %lumen
correlated significantly with minimal coronary resistance and
coronary reserve (Fig. 4 and 5).
Reproducibility of morphometric data. The biopsy area in
patients with HCM was comparable with the data of control
subjects (1.53 6 0.43 mm2 vs. 1.68 6 0.51 mm2), and the total
number of evaluable circular arteriolar profiles for determina-
tion of wall parameters from different sections were not
significantly different (13.6 6 8.8 vs. 12.6 6 5.1 per patient).
Intra- and interindividual observer variability was deter-
mined according to a previously reported protocol (19,24) by
repeating all measurements of 10 randomly chosen biopsy
samples by one observer (M.M.) (intraobserver variability) and
comparing the values of the first measurement with those of a
second observer (B.S.). There were no significant differences
for the mean of any parameter between the first and second
measurement of the first observer (intraobserver) and between
those of the second observer (interobserver). Results are given
in Table 4, with the mean value and SD of the absolute
differences of the observations as well as the coefficient of
variance expressed as the ratio of SD of the absolute differ-
ences to the mean of the observation in percent (20,24).
Discussion
Several reports from different groups have led to the belief
that coronary vasculature is abnormal in patients with HCM.
Our main finding is a reduced density and a diminished
%lumen of preterminal arterioles in the subendocardium of
patients with HCM that correlates with a diminished coronary
vasodilator capacity.
Vasodilator capacity in HCM. In fact, there are many
reports indicating perfusion abnormalities after exercise
(6,25,26), during pacing-induced tachycardia (4,12) and after
pharmacologic vasodilation (27) in patients with as well as
without history of chest pain who have HCM. In our study of
patients with HCM and chest pain, coronary vasodilation after
dipyridamole was significantly reduced as compared with con-
trol subjects. Oxygen consumption per 100 g of myocardium
was not significantly different for patients with obstructive and
nonobstructive HCM compared with control subjects, indicat-
ing that an increased metabolic demand did not explain the
limitation of coronary reserve in our patients. Cannon et al.
(10) reported a significantly increased myocardial oxygen
consumption and a higher coronary blood flow at rest in
patients with marked left ventricular outflow tract obstruction
compared with patients with nonobstructive cardiomyopathy.
Nevertheless, in this study at a maximal paced heart rate of 150
beats/min, most patients had angina pectoris and severe met-
abolic evidence of ischemia, whereas coronary resistance was
not significantly different between both groups. This supports
our finding that inadequate reduction of coronary resistance is
an important factor for compromised coronary vasodilator
reserve in HCM. Furthermore, our data are in accordance with
those of Camici et al. (27) who reported an impaired decrease
Figure 3. In HCM arteriolar density
is reduced, as is the arteriolar %lu-
men in the subendocardium. Mini-
mal coronary resistance after dipyr-
idamole (0.5 mg/kg) was increased in
HCM; consequently, coronary re-
serve was depressed. Open bars 5
control subjects (n 5 5); solid bars 5
patients with HCM (n 5 13). Data
shown are mean value 6 SD.
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in coronary resistance after dipyridamole in patients with
HCM by means of nitrogen-13 ammonia and dynamic positron
emission tomography compared with control subjects. Coro-
nary reserve was reduced in patients with as well as in those
without angina pectoris, but there was a tendency to a more
reduced coronary reserve in those with angina, indicating a
more serious disturbance in coronary microcirculation.
A reduced coronary vasodilator capacity after dipyridamole
has been partially explained by the increased extravascular
compressive forces in HCM (4). In our study, left ventricular
end-diastolic pressure tended to be higher, but did not reach
significance between patients with HCM and control subjects,
indicating the importance of other factors for increased mini-
mal coronary resistance. From experimental data it is well
known that dipyridamole, through adenosine, dilates intramu-
Figure 4. A decrease in arteriolar density correlates with an increase
in minimal coronary resistance (after dipyridamole 0.5 mg/kg) (A) and
a reduced vasodilator reserve (B). Circles 5 control subjects (n 5 5);
squares 5 patients with HCM (n 5 13).
Figure 5. A and B, A diminished %lumen of arterioles is associated
with an increase in minimal coronary resistance and a reduced
vasodilator reserve. Circles 5 control subjects (n 5 5); squares 5
patients with HCM (n 5 13).
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ral arterioles mainly in a non–endothelial-dependent way, and
this results in a more marked dilation of smaller rather than
larger arterioles and is greater for those in the subendocar-
dium than in the subepicardium (14,15,28). These data lead to
the hypothesis that the observed reduced coronary vasodilator
reserve in patients with HCM is caused by structural abnor-
malities of intramural coronary arterioles.
Altered architecture of intramural arterioles in HCM.
Maron et al. (11) qualitatively reported from autopsy studies
abnormal intramural coronary arteries in 40 of 48 patients with
HCM. Abnormal arteries were characterized by a thickening of
the vessel wall and a decrease in luminal size, which were more
frequently found in the interventricular septum than in the
anterior and posterior left ventricular free wall. Nevertheless,
in most patients only a small part of the arterial profiles were
abnormal, indicating a segmental character in the expression of
wall thickening over the total length of the intramural arteries.
Furthermore, the mean arterial diameter was 300 mm, with a
range of 50 to 1,300 mm, whereas qualitative abnormalities of
smaller arterioles were not reported.
In this quantitative morphometric investigation we did not
find a statistically significant thickening of the preterminal
arteriolar wall in HCM, but %lumen was significantly reduced,
indicating eutrophic vascular remodeling (29). Our data are in
accordance with those of Tanaka et al. (13), reporting a
reduced %lumen of arterioles in HCM with a diameter of
,60 mm in an autopsy study. Absolute wall area was not given
in this study. Nevertheless, progression of the disease into
dilated cardiomyopathy-like HCM was found to be associated
with an even more reduced %lumen of arterioles and arteries,
indicating the functional and prognostic importance of vascu-
lar remodelling of intramural coronary vessels in HCM (13).
The significant correlation between %lumen and coronary
reserve in our study supports this concept.
In this study, arteriolar density in the subendocardium was
found to be reduced, correlating inversely with coronary
resistance and concordantly with coronary reserve after phar-
macologic vasodilation. This finding gives further evidence of a
reduced total cross-sectional arteriolar lumen area that is
probably an important factor for the reported clinical and
metabolic signs of myocardial ischemia, especially in the
subendocardium (5–7). Furthermore, the observed increased
content of collagen in the subendocardium could be the
structural consequence of ischemia, as previously discussed
(11,13).
It should be noted that an inadequate relation between
arterioles and hypertrophied myocytes is apparent in HCM.
Myocyte hypertrophy correlated negatively with the density of
arterioles, which may point to an enhanced spreading of the
arteriolar bed. Perfusion abnormalities have been reported by
scintigraphic studies (5–7) as well as by positron emission
tomography studies (26) to a larger extent in the hypertrophied
than in the nonhypertrophied myocardium. Data from
pressure-induced hypertrophy reported an inadequate growth
of arterioles in the early process of experimental hypertrophy
(30), which was the most plausible cause for a reduced
coronary reserve. In human adult hearts, Rakusan et al. (31)
found an inadequate density of capillaries in left ventricular
pressure-overload hypertrophy. Besides an inadequate growth
of the intramural coronary arteries, a true loss of arteriolar
segments could be a further explanation, as reported by
Anversa et al. (32) in an experimental model.
Further investigations at the cellular and molecular level
seem necessary to clarify the processes leading to alterations in
the architecture of the intramyocardial coronary tree, regard-
ing the single arteriolar wall/lumen ratio and the number and
length of its branches.
Study limitations. Our data are restricted to the subendo-
cardium of the right ventricular septum. Thus, information
about the rest of the myocardium cannot be given. Neverthe-
less, the investigated part is involved in the process of hyper-
trophy as evidenced by hypertrophied myocytes. Secondary
processes (e.g., by increased pressure or contact with the mitral
leaflet) can be excluded. Sampling of arterioles in our study
depended on the depth gained by the bioptome, which was
comparable in patients and control subjects and thus excludes
bias achieved by ranking of arterioles because all arterioles
were investigated. Nevertheless, the observed greater variabil-
ity regarding arteriolar wall area and diameter between pa-
tients with HCM and control subjects might indicate a segmen-
tal process for arteriolar wall hypertrophy or the presence of an
afflicted minority of patients with true arteriolar wall thicken-
ing. Additionally, even if we could demonstrate reduced %lu-
men and diminished density of arterioles in HCM, correlating
both with increased minimal coronary resistance, total maxi-
mal dilated arteriolar lumen area for the whole heart cannot be
sufficiently concluded from our data. The influence of “stenotic
intramural coronary arteries” residing above preterminal arte-
rioles and potentially contributing to a diminished vasodilator
capacity could not be analyzed because arteries were not
obtained. Considering the relatively low correlations between
vascular alterations in the subendocardium and reduced coro-
nary reserve one might expect additional contributing factors,
Table 4. Intraobserver and Interobserver Variabilities of
Morphometric Investigations
Observer Variabilities Intraobserver Interobserver
Myocyte diameter (mm) 0.24 6 0.8 0.09 6 1.22
CV 6 5%, CE 6 2% CV 6 8%, CE 6 3%
Arteriolar wall area (mm2) 22.6 6 54.6 21.0 6 78.0
CV 6 28%, CE 6 9% CV 6 36%, CE 6 11%
Percent lumen area (%) 3.0 6 1.4 3.0 6 2.8
CV 6 5%, CE 6 2% CV 6 10%, CE 6 3%
Periarteriolar collagen
(mm2)
9.8 6 20.3 14 6 60
CV 6 15%, CE 6 5% CV 6 41%, CE 6 13%
Arteriolar density (n/mm2) 0.1 6 0.095 0.2 6 0.27
CV 6 9%, CE 6 3% CV 6 23%, CE 6 7%
Volume density of collagen
(Vv%)
0.2 6 0.63 0.38 6 1.64
CV 19%, CE 6 6% CV 46%, CE 6 15%
Values are expressed as mean value 6 SD of the absolute difference of the
observations (CV 5 coefficient of variance; SD of the absolute difference/mean
of observation) and as coefficient of error (CE).
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including the endothelium, in regard to coronary vasodilator
reserve. On the other hand, vascular remodeling and reduced
arteriolar density might be additive factors, which might cor-
relate better to functional data when taken together.
We thank Stefanie Wolff for skillful assistance and preparation of the morpho-
logic material, and Prof. Dr. Emeritus Waldemar Hort for revising and discussing
the morphologic techniques and the manuscript.
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